Published in J Neurochem on December 01, 1986
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev (2002) 2.15
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci (2001) 1.73
Dynamics affecting the primary charge transfer in photosynthesis. Science (1994) 1.39
Aescin Content in Embryogenic Callus and in Embryoids from Leaf Explants of Aesculus hippocastanum. Planta Med (1991) 1.39
A single center's experience with 308 free flaps for repair of head and neck cancer defects. Plast Reconstr Surg (1994) 1.36
On surveillance methods for congenital malformations. Stat Med (1987) 1.29
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids. Exp Neurol (2001) 1.25
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther (1984) 1.22
Carrier-mediated release of neurotransmitters. Trends Neurosci (1993) 1.22
Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol (1977) 1.21
Multiple GABAB receptors. Trends Pharmacol Sci (1993) 1.21
Synaptosomes still viable after 25 years of superfusion. Neurochem Res (2000) 1.13
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther (1979) 1.07
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis (1993) 1.06
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol (1993) 1.05
Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol (1986) 1.03
Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. J Pharm Pharmacol (1976) 1.03
Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. Life Sci I (1973) 1.03
In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol (1999) 1.03
Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci (1998) 1.03
Release and exchange studies relating to the synaptosomal uptake of GABA. J Neurochem (1975) 1.02
Dynamics of hydration in hen egg white lysozyme. J Mol Biol (2001) 1.01
An approximate CUSUM procedure for surveillance of health events. Stat Med (1999) 1.00
Comparison of strategies for preventing abdominal-wall weakness after TRAM flap breast reconstruction. Plast Reconstr Surg (1992) 1.00
Intrinsic compressibility and volume compression in solvated proteins by molecular dynamics simulation at high pressure. Proc Natl Acad Sci U S A (1996) 0.99
Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics (2009) 0.99
Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol (1979) 0.98
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology (1988) 0.97
A method for optimizing skin graft healing and outcome of wounds of the penile shaft and scrotum. Ann Plast Surg (1993) 0.97
Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr Metab Cardiovasc Dis (2008) 0.96
Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther (1992) 0.96
Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature (1974) 0.96
Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther (1984) 0.95
Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex. Br J Pharmacol (1997) 0.95
Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther (1989) 0.94
Lateral thigh free flap in head and neck reconstruction. Plast Reconstr Surg (1995) 0.94
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol (1975) 0.94
d-amphetamine and the release of 3H-norepinephrine from synaptosomes. Eur J Pharmacol (1974) 0.93
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol (1990) 0.93
Exploratory tools for disease mapping in geographical epidemiology. Stat Med (1996) 0.92
Multiple sclerosis among shoe and leather workers: an epidemiological survey in Florence. Acta Neurol Scand (1982) 0.92
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther (1992) 0.91
Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis (2008) 0.91
Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol (1991) 0.91
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br J Pharmacol (2006) 0.90
Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur J Pharmacol (1987) 0.90
Non-parametric maximum likelihood estimators for disease mapping. Stat Med (2001) 0.89
On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J Pharmacol Exp Ther (1985) 0.89
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett (1989) 0.89
Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.89
GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology (2000) 0.89
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol (1995) 0.89
Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Effects of an acute increase in plasma triglyceride levels on glucose metabolism in man. Metabolism (1995) 0.88
3H-thymidine long survival autoradiography as a method for dating the time of neuronal origin in the chick embryo: the locus coeruleus and cerebellar Purkinje cells. J Comp Neurol (1981) 0.88
Infections and antimicrobial resistance in long term care facilities: a national prevalence study. Ann Ig (2013) 0.88
Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist. Eur J Neurosci (1998) 0.87
Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. J Pharmacol Exp Ther (1974) 0.87
Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagna Region. Infection (2007) 0.87
Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors. Br J Pharmacol (1998) 0.87
Studies on dopamine uptake and release in synaptosomes. Adv Biochem Psychopharmacol (1978) 0.87
gamma-Aminobutyric acid (GABA) autoreceptors in rat cerebral cortex and spinal cord represent pharmacologically distinct subtypes of the GABAB receptor. J Pharmacol Exp Ther (1993) 0.87
Cancer mortality in migrant populations within Italy. Tumori (1988) 0.86
Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler Thromb Vasc Biol (1995) 0.86
A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings. Neurochem Res (1980) 0.86
Alpha 2-adrenoceptors in rat hypothalamus and cerebral cortex: functional evidence for pharmacologically distinct subpopulations. Eur J Pharmacol (1985) 0.86
Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol (1998) 0.86
Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex. Eur J Pharmacol (1988) 0.86
Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol (1996) 0.86
Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol (1994) 0.85
Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J Neurosci (1994) 0.85
Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes. Mol Pharmacol (1977) 0.85
Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms. Br J Pharmacol (2010) 0.85
Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. Eur J Pharmacol (1985) 0.85
GABA and glutamate uptake by subcellular fractions enriched in synaptosomes: critical evaluation of some methodological aspects. Brain Res (1973) 0.85
(-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain. Neuropharmacology (1987) 0.84
GABAergic nerve terminals in rat hippocampus possess alpha 2-adrenoceptors regulating GABA release. Neurosci Lett (1987) 0.84
Methodological problems and the role of statistics in cluster response studies: a framework. Eur J Epidemiol (1999) 0.84
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study. Melanoma Res (2003) 0.84
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals. Br J Pharmacol (2007) 0.84
Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex. J Neurochem (1993) 0.84
In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br J Pharmacol (1996) 0.83
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther (1986) 0.83
Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. J Pharmacol Exp Ther (1983) 0.83
Progress in infection prevention and control in Italy: a nationwide survey. J Hosp Infect (2010) 0.83
Deep brain stimulation in Parkinson's disease patients: biochemical evidence. J Neural Transm Suppl (2006) 0.83
Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience (1993) 0.83
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? Curr Pharm Des (2010) 0.83